{"id":75389,"date":"2025-07-22T15:56:56","date_gmt":"2025-07-22T13:56:56","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=75389"},"modified":"2025-07-22T17:10:57","modified_gmt":"2025-07-22T15:10:57","slug":"new-funding-for-embls-cutting-edge-imaging-technology-services","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/","title":{"rendered":"New funding for EMBL\u2019s cutting-edge imaging technology services"},"content":{"rendered":"\n

A well-established EMBL partner, Boehringer Ingelheim Stiftung (BIS), is providing \u20ac7 million to continue the successful development of the EMBL Imaging Centre (IC). Since its inception, the highly committed staff have positioned the EMBL IC as an internationally leading institution for cutting-edge imaging technologies. This is already the second round of funding by BIS, enabling EMBL to maintain and recruit additional highly qualified staff members who will further develop imaging technology services at the EMBL IC and make them accessible to the international research community.<\/p>\n\n\n\n

\u201cWe\u2019re proud to support the EMBL Imaging Centre,\u201d said Christoph Boehringer, chairman of BIS\u2019s executive committee. \u201cIts impressive progress since our initial funding reflects its far-reaching potential. With a clear long-term vision and a strong commitment to developing cutting-edge technologies and making them broadly accessible, it will drive scientific and technological progress for the benefit of the entire research community.\u201d<\/p>\n\n\n\n

In 2017, when the EMBL IC’s construction was just being planned, BIS committed \u20ac5 million towards training and user support, which enabled the recruitment and funding for highly qualified staff for two electron and light microscopy service teams. Today, these staff provide training and support to international scientists who visit the EMBL IC to get hands-on experience and training on the latest imaging technologies.<\/p>\n\n\n\n

From its inception, the EMBL IC has established itself as a leading international user centre for cutting-edge microscopy technologies, meeting previously unmet needs of the European scientific community. From mid-2021, when it opened its doors, until December 2024, its service teams have supported more than 290 projects and training sessions for scientists from 27 countries at over 120 scientific institutions, far exceeding the originally planned operational scope.<\/p>\n\n\n\n

The EMBL IC has pioneered open access to groundbreaking new technologies such as MINFLUX and in situ<\/em> cryo-electron tomography. At the same time, other emerging technologies, such as new correlative X-ray and cryo-electron microscopy imaging methods, label-free methods like Brillouin microscopy, and real-time super-resolution microscopy technologies, are expected to have a similarly significant impact on biomedical research once transferred to the service level.<\/p>\n\n\n\n

\u201cIt\u2019s an exciting time for the EMBL Imaging Centre, and this generous support from Boehringer Ingelheim Stiftung will make it possible to continue raising the level of research and services we can do here,\u201d said Peer Bork, Interim EMBL Director General. \u201cIt ensures that the EMBL IC can maximise its service and training capacities and lay the foundation for continuing to be the leading centre in Europe in the future \u2013 the first to establish groundbreaking, next-generation imaging technologies with significant potential for impact in the life sciences as accessible services.\u201d<\/p>\n\n\n\n

\n
\n

\n \n Boehringer Ingelheim Stiftung \n <\/path>\n <\/svg>\n <\/a>\n <\/h3>\n

Boehringer Ingelheim Stiftung is an independent, non-profit foundation that is committed to promoting the medical, biological, chemical, and pharmaceutical sciences. It was established in 1977 by Hubertus Liebrecht (1931\u20131991), a member of the shareholder family of the Boehringer Ingelheim company. Through its funding programmes Exploration Grants, Plus 3, and Rise up!, the foundation supports excellent scientists during critical stages of their careers. It also endows awards for junior scientists in Germany. Additionally, it funds institutional projects in the life sciences, such as the AITHYRA institute in Vienna and a new research department (BioAI) at the Center for Systems Biology in Dresden, which both combine biomedicine and AI. Other supported institutions include the Institute of Molecular Biology (IMB) in Mainz and the European Molecular Biology Laboratory (EMBL) in Heidelberg, both in Germany. <\/p>\n <\/div>\n<\/article>\n\n\n\n\n

\n
\n

\n European Molecular Biology Laboratory <\/h3>\n

The European Molecular Biology Laboratory (EMBL) is Europe\u2019s life sciences laboratory. We provide leadership and coordination for the life sciences across Europe, and our world-class fundamental research seeks collaborative and interdisciplinary solutions for some of society\u2019s biggest challenges. We provide training for students and scientists, drive the development of new technology and methods in the life sciences, and offer state-of-the-art research infrastructure for a wide range of experimental and data services.\r\nEMBL is an intergovernmental organisation with 29 member states, one associate member, and one prospective member. At our six sites in Barcelona, Grenoble, Hamburg, Heidelberg, Hinxton near Cambridge, and Rome, we seek to better understand life in its natural context, from molecules to ecosystems.\r\n<\/p>\n <\/div>\n<\/article>\n\n\n\n\n

\n\n\n\n

Neue F\u00f6rderung f\u00fcr Services und Training in hochmodernen Mikroskopietechnologien am EMBL<\/h1>\n\n\n\n

Boehringer Ingelheim Stiftung f\u00f6rdert mit weiteren 7 Millionen Euro das EMBL Imaging Centre in Heidelberg<\/h2>\n\n\n\n

Als langj\u00e4hriger Partner des Europ\u00e4ischen Laboratorium f\u00fcr Molekularbiologie (EMBL) hat die Boehringer Ingelheim Stiftung (BIS) weitere 7 Millionen Euro zugesagt, um die erfolgreiche Entwicklung des EMBL Imaging Centre fortzuf\u00fchren. Seit seiner Gr\u00fcndung hat das hoch engagierte Team das Imaging Centre als international f\u00fchrende Einrichtung f\u00fcr Spitzentechnologien im Bereich der Bildgebung etablieren k\u00f6nnen. Dies ist bereits die zweite F\u00f6rderung durch die BIS, mit der das EMBL weitere hochqualifizierte Teammitglieder einstellen kann, die die Bildtechnologien am Imaging Centre weiterentwickeln und sie f\u00fcr die internationale Forschungsgemeinde nutzbar machen.<\/p>\n\n\n\n

\u201eWir sind stolz darauf, das EMBL Imaging Centre zu unterst\u00fctzen\u201c, sagte Christoph Boehringer, Vorsitzender des Stiftungsvorstands. \u201eDie beeindruckenden Fortschritte seit unserer ersten F\u00f6rderung zeugen von seinem weitreichenden Potenzial. Mit einer klaren langfristigen Vision und dem Ziel, Spitzentechnologien zu entwickeln und einer breiten Wissenschaftscommunity zug\u00e4nglich zu machen, wird es den wissenschaftlichen und technologischen Fortschritt im Interesse der weltweiten Forschungsgemeinschaft mitgestalten.\u201c<\/p>\n\n\n\n

Im Jahr 2017, als die Planung f\u00fcr den Bau des Zentrums gerade begann, stellte die BIS bereits 5 Millionen Euro f\u00fcr Ausbildung und Unterst\u00fctzung der Nutzer des Zentrums zur Verf\u00fcgung. Diese F\u00f6rderung erm\u00f6glichte die Einstellung hochqualifizierten Personals f\u00fcr zwei Serviceteams in der Elektronen- und Lichtmikroskopie. Heute bieten diese Mitarbeitenden diverse Schulungen an und unterst\u00fctzen internationale Wissenschaftlerinnen und Wissenschaftler, die das EMBL Imaging Centre f\u00fcr praktische Erfahrungen und Training in den neuesten Bildgebungstechnologien besuchen. <\/p>\n\n\n\n

Seit seiner Gr\u00fcndung hat sich das Imaging Centre des EMBL als f\u00fchrendes internationales Nutzerzentrum f\u00fcr hochmoderne Mikroskopietechnologien etabliert und deckt damit bislang ungedeckte Bed\u00fcrfnisse der europ\u00e4ischen Wissenschaftsgemeinschaft ab. Von der Er\u00f6ffnung im Juni 2021 bis Dezember 2024 haben die Serviceteams bereits mehr als 290 Projekte und Schulungseinheiten f\u00fcr Forschende aus 27 L\u00e4ndern und \u00fcber 120 wissenschaftlichen Einrichtungen unterst\u00fctzt \u2013 deutlich mehr als urspr\u00fcnglich geplant.<\/p>\n\n\n\n

Das EMBL Imaging Centre war Vorreiter beim offenen Zugang zu bahnbrechenden neuen Technologien wie MINFLUX und in situ Kryo-Elektronentomographie. Es ist zu erwarten, dass weitere korrelative Bildgebungsverfahren \u2013 wie die Verbindung von R\u00f6ntgen- und Kryo-Elektronenmikroskopie, sowie neue markierungsfreie Methoden wie Brillouin-Mikroskopie und Echtzeit-Superaufl\u00f6sungsmikroskopie \u2013 einen ebenso bedeutenden Einfluss auf die biomedizinische Forschung haben, sobald sie in dienstleistungsf\u00e4hige Abl\u00e4ufe und den regul\u00e4ren Servicebetrieb \u00fcberf\u00fchrt werden.<\/p>\n\n\n\n

\u201eEs ist ein wichtiger Zeitpunkt f\u00fcr das EMBL Imaging Centre, und die gro\u00dfz\u00fcgige Unterst\u00fctzung der Boehringer Ingelheim Stiftung wird es uns erm\u00f6glichen, das Niveau unserer Forschung und Dienstleistungen noch weiter zu steigern\u201c, sagte Peer Bork, Interim Generaldirektor des EMBL. \u201eDank dieser F\u00f6rderung wird sichergestellt, dass das Imaging Centre seine Kapazit\u00e4ten in Service und Ausbildung voll aussch\u00f6pfen und erweitern kann. Damit k\u00f6nnen wir den Grundstein daf\u00fcr legen, auch in Zukunft das f\u00fchrende Zentrum in Europa zu bleiben \u2013 das erste, das bahnbrechende Bildgebungstechnologien der n\u00e4chsten Generation mit erheblichem Potenzial f\u00fcr die Lebenswissenschaften als zug\u00e4ngliche Dienste etabliert.\u201c<\/p>\n\n\n\n

\n
\n

\n \n Boehringer Ingelheim Stiftung \n <\/path>\n <\/svg>\n <\/a>\n <\/h3>\n

Die Boehringer Ingelheim Stiftung ist eine rechtlich selbstst\u00e4ndige, gemeinn\u00fctzige Stiftung und f\u00f6rdert die medizinische, biologische, chemische und pharmazeutische Wissenschaft. Errichtet wurde sie 1977 von Hubertus Liebrecht, einem Mitglied der Gesellschafterfamilie des Unternehmens Boehringer Ingelheim. Durch ihre F\u00f6rderprogramme Exploration Grants, Plus 3 und Rise up! unterst\u00fctzt sie exzellente Forschende in entscheidenden Karrierephasen. Zudem verleiht sie den renommierten Heinrich-Wieland-Preis sowie Preise f\u00fcr aufstrebende wissenschaftliche Talente. Au\u00dferdem f\u00f6rdert sie institutionelle Projekte in den Lebenswissenschaften, wie das AITHYRA-Institut in Wien und einen neuen Forschungsbereich am Zentrum f\u00fcr Systembiologie in Dresden (BioAI Dresden), die beide Biomedizin mit KI verbinden. Weitere Institute, die die Stiftung f\u00f6rdert, sind das Institut f\u00fcr Molekulare Biologie (IMB) in Mainz und das European Molecular Biology Laboratory (EMBL) in Heidelberg. <\/p>\n <\/div>\n<\/article>\n\n\n\n\n

\n
\n

\n Europ\u00e4isches Laboratorium f\u00fcr Molekularbiologie <\/h3>\n

Das Europ\u00e4ische Laboratorium f\u00fcr Molekularbiologie (EMBL) ist Europas Forschungseinrichtung f\u00fcr Lebenswissenschaften. Als wissenschaftlicher Wegbereiter koordinieren wir biowissenschaftliche Forschung in ganz Europa. Unsere herausragende Grundlagenforschung sucht nach kooperativen und interdisziplin\u00e4ren L\u00f6sungen f\u00fcr einige der gr\u00f6\u00dften Herausforderungen unserer Gesellschaft. Unser Fokus liegt au\u00dferdem auf der Ausbildung von Studierenden und Forschenden, der (Weiter-)Entwicklung neuer Technologien und Methoden, und auf der Bereitstellung einer hochmodernen Forschungsinfrastruktur mit einem breiten Angebot an Experiment- und Datendiensten.\r\nDas EMBL ist eine zwischenstaatliche Organisation mit 29 Mitgliedsstaaten, einem assoziierten Mitglied und einem Mitgliedskandidaten. An unseren sechs Standorten in Barcelona, Grenoble, Hamburg, Heidelberg, Hinxton bei Cambridge und Rom erforschen wir das Leben in seinem nat\u00fcrlichen Kontext, von Molek\u00fclen bis hin zu \u00d6kosystemen.\r\n<\/p>\n <\/div>\n<\/article>\n\n","protected":false},"excerpt":{"rendered":"

Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.<\/p>\n","protected":false},"author":100,"featured_media":75487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17595],"tags":[793,796,13072],"embl_taxonomy":[5158,5802],"class_list":["post-75389","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connections","tag-imaging-centre","tag-ord","tag-support-embl","embl_taxonomy-embl-imaging-centre","embl_taxonomy-support-embl"],"acf":{"vfwp-news_embl_taxonomy":[5802,5158],"featured":true,"show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"article_intro":"

Boehringer Ingelheim Stiftung commits \u20ac7 million to support the EMBL Imaging Centre in Heidelberg<\/p>\n","related_links":[{"link_description":"Funding agreed for imaging centre ","link_url":"https:\/\/www.embl.org\/news\/lab-matters\/funding-agreed-imaging-technology-centre\/"},{"link_description":"12 moments of philanthropy: #4 EMBL Imaging Centre ","link_url":"https:\/\/www.embl.org\/news\/connections\/12-moments-of-philanthropy-4-embl-imaging-centre\/"},{"link_description":"Foundation stone laid for EMBL Imaging Centre ","link_url":"https:\/\/www.embl.org\/news\/events\/foundation-stone-laid-for-embl-imaging-centre\/"}],"source_article":false,"in_this_article":[{"heading_description":"","anchor":""}],"press_contact":"EMBL Generic","article_translations":[{"translation_language":"Deutsch","translation_anchor":"#a1"}],"languages":"","vf_locked":false},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"ef0437fc-a5b7-4c73-bcfd-63bff16cb35e\";i:2;s:36:\"41875e2f-34f0-4775-8df3-02ac1e34b0b1\";}","parents":[],"name":["EMBL Imaging Centre"],"slug":"embl-imaging-centre","description":"What > Services and facilities > EMBL Imaging Centre"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What > About EMBL > Support EMBL"}],"yoast_head":"\nNew funding for EMBL\u2019s cutting-edge imaging technology services | EMBL<\/title>\n<meta name=\"description\" content=\"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New funding for EMBL\u2019s cutting-edge imaging technology services | EMBL\" \/>\n<meta property=\"og:description\" content=\"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-22T13:56:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-22T15:10:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ivy Kupec\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ivy Kupec\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\"},\"author\":{\"name\":\"Ivy Kupec\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\"},\"headline\":\"New funding for EMBL\u2019s cutting-edge imaging technology services\",\"datePublished\":\"2025-07-22T13:56:56+00:00\",\"dateModified\":\"2025-07-22T15:10:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\"},\"wordCount\":944,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg\",\"keywords\":[\"imaging centre\",\"ord\",\"support embl\"],\"articleSection\":[\"Connections\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\",\"url\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\",\"name\":\"New funding for EMBL\u2019s cutting-edge imaging technology services | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg\",\"datePublished\":\"2025-07-22T13:56:56+00:00\",\"dateModified\":\"2025-07-22T15:10:57+00:00\",\"description\":\"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg\",\"width\":1000,\"height\":600,\"caption\":\"Representatives of EMBL and of the Boehringer Ingelheim Stiftung at the EMBL Imaging Centre in Heidelberg. Credit: Stuart Ingham\/EMBL\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\",\"name\":\"Ivy Kupec\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"caption\":\"Ivy Kupec\"},\"url\":\"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New funding for EMBL\u2019s cutting-edge imaging technology services | EMBL","description":"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/","og_locale":"en_US","og_type":"article","og_title":"New funding for EMBL\u2019s cutting-edge imaging technology services | EMBL","og_description":"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.","og_url":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2025-07-22T13:56:56+00:00","article_modified_time":"2025-07-22T15:10:57+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","type":"image\/jpeg"}],"author":"Ivy Kupec","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Ivy Kupec","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/"},"author":{"name":"Ivy Kupec","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274"},"headline":"New funding for EMBL\u2019s cutting-edge imaging technology services","datePublished":"2025-07-22T13:56:56+00:00","dateModified":"2025-07-22T15:10:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/"},"wordCount":944,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","keywords":["imaging centre","ord","support embl"],"articleSection":["Connections"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/","url":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/","name":"New funding for EMBL\u2019s cutting-edge imaging technology services | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","datePublished":"2025-07-22T13:56:56+00:00","dateModified":"2025-07-22T15:10:57+00:00","description":"Boehringer Ingelheim Stiftung commits \u20ac7 million to support key technology development in life sciences research.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/connections\/new-funding-for-embls-cutting-edge-imaging-technology-services\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","width":1000,"height":600,"caption":"Representatives of EMBL and of the Boehringer Ingelheim Stiftung at the EMBL Imaging Centre in Heidelberg. Credit: Stuart Ingham\/EMBL"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274","name":"Ivy Kupec","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","caption":"Ivy Kupec"},"url":"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/07\/Featured_20250722_ORD-IC-HD-Signing-Event-244.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/75389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/100"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=75389"}],"version-history":[{"count":9,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/75389\/revisions"}],"predecessor-version":[{"id":75491,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/75389\/revisions\/75491"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/75487"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=75389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=75389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=75389"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=75389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}